MedPath

Ofloxacin

Ofloxacin Ophthalmic Solution 0.3% (Sterile)

Approved
Approval ID

c8020ad4-ac74-4ceb-863e-94da605cf23f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 1, 2022

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ofloxacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63187-268
Application NumberANDA076622
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ofloxacin
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateApril 1, 2022
FDA Product Classification

INGREDIENTS (6)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
OFLOXACINActive
Quantity: 3 mg in 1 mL
Code: A4P49JAZ9H
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ofloxacin - FDA Drug Approval Details